<?xml version="1.0" encoding="UTF-8"?>
<ref id="B76-vaccines-08-00038">
 <label>76.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <name>
    <surname>Edmunds</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Jarvis</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Benefits Risk Analysis of Vaccination of Pregnant Women with rVSV-ZEBOV as Part of Expanded Access Programme. Presentation to WHO SAGE. October 2018</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.who.int/immunization/sage/meetings/2018/october/presentations_background_docs/en/index1.html" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/immunization/sage/meetings/2018/october/presentations_background_docs/en/index1.html</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2019-12-23">(accessed on 23 December 2019)</date-in-citation>
 </element-citation>
</ref>
